<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>10(3)</volume><submitter>Dong Y</submitter><pubmed_abstract>&lt;h4>Background&lt;/h4>As a type of non-coding RNA, circular RNAs (circRNAs) are considered to be functional molecules associated with human cancers. An increasing number of circRNAs have been verified in malignant progression in a number of cancers. The circRNA, circFBXW7, has been proven to play an important role in tumor proliferation and metastasis. However, whether circFBXW7 influences progression in lung adenocarcinoma (LUAD) remains unclear.&lt;h4>Methods&lt;/h4>Quantitative real-time reverse transcriptase PCR (qRT-PCR) was used to verify circFBXW7 in LUAD cell lines and LUAD tissues. Kaplan-Meier analysis was then used to compare the disease-free survival (DFS) and overall survival (OS) of these LUAD patients. The biological function of circFBXW7 was examined by overexpression and knockdown of circFBXW7 using MTT assay, EdU assay, wound-healing assay, and Transwell &lt;i>in vitro&lt;/i> assays. To explore the mechanism of the circFBXW7, RNA pull-down assay, dual luciferase reporter assay, and RNA immunoprecipitation (RIP) assay were employed to examine the interaction between circFBXW7 and miR-942-5p. Western blot was used to study the fundamental proteins associated with the epithelial-mesenchymal transition (EMT) pathway. &lt;i>In vivo&lt;/i> studies with BALB/c nude mice subcutaneously injected with cells stably overexpressing circFBXW7 were performed to further validate the &lt;i>in vitro&lt;/i> results.&lt;h4>Results&lt;/h4>circFBXW7 was downregulated in LUAD cell lines and tissues, and LUAD patients with lower levels had shorter DFS and OS. The &lt;i>in vitro&lt;/i> study showed that circFBXW7 overexpression inhibited proliferation and migration of A549 and HCC2279 cell lines. These results were confirmed by circFBXW7 knockdown, which showed the reverse effect. The &lt;i>in vivo&lt;/i> model showed that the circRNA levels influenced the tumor growth. Finally, we determined that circFBXW7 target miRNA-942-5p which regulates the EMT gene BARX2. The modulation of circFBXW7 levels produced significant changes in EMT genes &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>.&lt;h4>Conclusions&lt;/h4>Our findings showed that circFBXW7 inhibits proliferation and migration by controlling the miR-942-5p/BARX2 axis in LUAD cell lines and its levels correlates with patient survival suggesting that regulating circFBXW7 could have therapeutic value in treating LUAD patients.</pubmed_abstract><journal>Translational lung cancer research</journal><pagination>1457-1473</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8044477</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p.</pubmed_title><pmcid>PMC8044477</pmcid><pubmed_authors>Dong Y</pubmed_authors><pubmed_authors>Huang Z</pubmed_authors><pubmed_authors>Qiu T</pubmed_authors><pubmed_authors>Du W</pubmed_authors><pubmed_authors>Wo Y</pubmed_authors><pubmed_authors>Liu A</pubmed_authors><pubmed_authors>Yun T</pubmed_authors><pubmed_authors>Xuan Y</pubmed_authors><pubmed_authors>Sun X</pubmed_authors><pubmed_authors>Su W</pubmed_authors><pubmed_authors>Navarro A</pubmed_authors><pubmed_authors>Jiao W</pubmed_authors></additional><is_claimable>false</is_claimable><name>circFBXW7 attenuates malignant progression in lung adenocarcinoma by sponging miR-942-5p.</name><description>&lt;h4>Background&lt;/h4>As a type of non-coding RNA, circular RNAs (circRNAs) are considered to be functional molecules associated with human cancers. An increasing number of circRNAs have been verified in malignant progression in a number of cancers. The circRNA, circFBXW7, has been proven to play an important role in tumor proliferation and metastasis. However, whether circFBXW7 influences progression in lung adenocarcinoma (LUAD) remains unclear.&lt;h4>Methods&lt;/h4>Quantitative real-time reverse transcriptase PCR (qRT-PCR) was used to verify circFBXW7 in LUAD cell lines and LUAD tissues. Kaplan-Meier analysis was then used to compare the disease-free survival (DFS) and overall survival (OS) of these LUAD patients. The biological function of circFBXW7 was examined by overexpression and knockdown of circFBXW7 using MTT assay, EdU assay, wound-healing assay, and Transwell &lt;i>in vitro&lt;/i> assays. To explore the mechanism of the circFBXW7, RNA pull-down assay, dual luciferase reporter assay, and RNA immunoprecipitation (RIP) assay were employed to examine the interaction between circFBXW7 and miR-942-5p. Western blot was used to study the fundamental proteins associated with the epithelial-mesenchymal transition (EMT) pathway. &lt;i>In vivo&lt;/i> studies with BALB/c nude mice subcutaneously injected with cells stably overexpressing circFBXW7 were performed to further validate the &lt;i>in vitro&lt;/i> results.&lt;h4>Results&lt;/h4>circFBXW7 was downregulated in LUAD cell lines and tissues, and LUAD patients with lower levels had shorter DFS and OS. The &lt;i>in vitro&lt;/i> study showed that circFBXW7 overexpression inhibited proliferation and migration of A549 and HCC2279 cell lines. These results were confirmed by circFBXW7 knockdown, which showed the reverse effect. The &lt;i>in vivo&lt;/i> model showed that the circRNA levels influenced the tumor growth. Finally, we determined that circFBXW7 target miRNA-942-5p which regulates the EMT gene BARX2. The modulation of circFBXW7 levels produced significant changes in EMT genes &lt;i>in vitro&lt;/i> and &lt;i>in vivo&lt;/i>.&lt;h4>Conclusions&lt;/h4>Our findings showed that circFBXW7 inhibits proliferation and migration by controlling the miR-942-5p/BARX2 axis in LUAD cell lines and its levels correlates with patient survival suggesting that regulating circFBXW7 could have therapeutic value in treating LUAD patients.</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Mar</publication><modification>2025-04-27T00:16:27.563Z</modification><creation>2025-04-06T17:46:41.057Z</creation></dates><accession>S-EPMC8044477</accession><cross_references><pubmed>33889522</pubmed><doi>10.21037/tlcr-21-230</doi></cross_references></HashMap>